Futura Medical (FUM) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Oct 2022 04:35 PM
RNS
Price Monitoring Extension
12 Oct 2022 12:25 PM
RNS
TR-1: Notification of major holdings
04 Oct 2022 05:31 PM
RNS
Total Voting Rights
03 Oct 2022 07:00 AM
RNS
Application to the US FDA for MED3000
16 Sep 2022 09:57 AM
RNS
PDMR Dealing and Total Voting Rights
13 Sep 2022 07:00 AM
RNS
Futura Medical Interim Results 2022
01 Sep 2022 07:00 AM
RNS
Notice of Interim Results
31 Aug 2022 07:00 AM
RNS
Highly positive FM71 Phase 3 Study Results
12 Jul 2022 04:41 PM
RNS
Second Price Monitoring Extn
12 Jul 2022 04:35 PM
RNS
Price Monitoring Extension
28 Jun 2022 03:58 PM
RNS
Futura Medical AGM Results
28 Jun 2022 07:00 AM
RNS
Futura Medical AGM Statement
07 Jun 2022 01:33 PM
RNS
TR-1: Notification of major holdings
01 Jun 2022 07:00 AM
RNS
Notice of AGM and Availability of Annual Report
31 May 2022 07:00 AM
RNS
Block Listing Six Monthly Return
24 May 2022 11:40 AM
RNS
TR-1: Notification of major holdings
23 May 2022 10:35 AM
RNS
Agreement with Cooper Consumer Health - Correction
23 May 2022 07:00 AM
RNS
MED3000 Collaboration in EEA, UK & Switzerland
17 May 2022 03:56 PM
RNS
TR-1: Notification of major holdings
16 May 2022 02:51 PM
RNS
TR-1: Notification of major holdings
13 May 2022 12:12 PM
RNS
TR-1: Notification of major holdings
06 May 2022 04:41 PM
RNS
Second Price Monitoring Extn
06 May 2022 04:35 PM
RNS
Price Monitoring Extension
26 Apr 2022 07:00 AM
RNS
Full Year Results 2021
14 Apr 2022 03:54 PM
RNS
Futura Medical Notice of Preliminary Results 2021
11 Apr 2022 04:28 PM
RNS
TR-1: Notification of major holdings
01 Apr 2022 04:58 PM
RNS
TR-1: Notification of major holdings
23 Mar 2022 07:00 AM
RNS
Futura Announces Collaboration with Menarini
02 Feb 2022 05:30 PM
RNS
TR-1:Notification of major holdings
13 Jan 2022 10:32 AM
RNS
Remuneration of Non-Executive Directors and TVR
20 Dec 2021 07:00 AM
RNS
US regulatory and commercial update for MED3000
02 Dec 2021 12:02 PM
RNS
TR-1: Notification of major holdings
30 Nov 2021 07:00 AM
RNS
Block Listing Six Monthly Return
30 Nov 2021 07:00 AM
RNS
Futura Medical plc Total Voting Rights
28 Oct 2021 07:00 AM
RNS
Futura Medical plc Board Appointment
08 Oct 2021 07:00 AM
RNS
Futura Medical plc Board Appointment
05 Oct 2021 04:05 PM
RNS
Director/PDMR Shareholding
29 Sep 2021 07:00 AM
RNS
Interim Results for Six Months ended 30 June 2021
27 Sep 2021 07:00 AM
RNS
Futura Announces Collaboration with Labatec Pharma
17 Sep 2021 07:00 AM
RNS
Notice of Interim Results
15 Sep 2021 07:00 AM
RNS
First Patient visit in MED3000 Confirmatory Study
08 Sep 2021 03:49 PM
RNS
TR1: Notification of Major Holdings
31 Aug 2021 07:00 AM
RNS
Futura Medical Announces Collaboration of MED3000
19 Jul 2021 07:00 AM
RNS
FDA regulatory and commercial update for MED3000
28 Jun 2021 01:26 PM
RNS
Result of AGM
28 Jun 2021 07:00 AM
RNS
AGM Statement
25 Jun 2021 02:55 PM
RNS
TR1: Notification of Major Holdings
15 Jun 2021 03:48 PM
RNS
TR-1: Notification of major holdings
09 Jun 2021 03:58 PM
RNS
TR-1: Notification of major holdings
03 Jun 2021 04:19 PM
RNS
TR-1: Notification of major holdings

Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

FUM share price listed on AIM in 2003.

UK 100

Latest directors dealings